UPDATE: Goldman Sachs Upgrades Phathom Pharmaceuticals (PHAT) to Neutral
Tweet Send to a Friend
(Updated - May 12, 2021 4:22 AM EDT)
Goldman Sachs analyst Paul Choi upgraded Phathom Pharmaceuticals (NASDAQ: PHAT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Paul Choi upgraded Phathom Pharmaceuticals (NASDAQ: PHAT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
